Please assess the completion status of the following clinical trial:

Trial Title: Epidural Analgesia Versus IV Analgesia in Lumbar Spine Fusions

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients who are scheduled for elective Transforaminal Lumbar Interbody Fusion surgery~Exclusion Criteria:~* Baseline cognitive deficits sufficient to make objective pain self-assessments unreliable in the estimation of the Study Investigators.~* Inability to follow directions or comprehend the English language.~* Females who are pregnant as determined by positive pregnancy test on or before the day of surgery.~* Prisoners.~* Patient refusal to provide informed consent.~* Allergy to amide local anesthetics (lidocaine, bupivacaine, ropivacaine).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Intravenous opioids (Type: EXPERIMENTAL): This is the standard of care method for post-operative analgesia following lumbar spine fusion surgery. Participants randomly assigned to this arm will receive Intravenous Patient-Controlled Analgesia (IVPCA) with dilaudid (or other opioid) for post-operative pain control.
- Epidural Catheter (Type: EXPERIMENTAL): The intervention to be tested in this study against standard intravenous opioids is infusion of local anesthetic and dilaudid via epidural catheter for post-operative pain control in patients undergoing lumbar spine fusion surgery.

Based on this trial design, predict the completion outcome and termination type (if applicable).